| Literature DB >> 29602814 |
Maxime Patout1,2,3, Gill Arbane1,3, Antoine Cuvelier2, Jean Francois Muir2, Nicholas Hart1,3,4, Patrick Brian Murphy1,3,4.
Abstract
Polysomnography (PSG) is recommended for non-invasive ventilation (NIV) set-up in patients with chronic respiratory failure. In this pilot randomised clinical trial, we compared the physiological effectiveness of NIV set-up guided by PSG to limited respiratory monitoring (LRM) and nurse-led titration in patients with COPD-obstructive sleep apnoea (OSA) overlap. The principal outcome of interest was change in daytime arterial partial pressure of carbon dioxide (PaCO2) at 3 months. Fourteen patients with daytime PaCO2 >6 kPa and body mass index >30 kg/m2 were recruited. At 3 months, PaCO2 was reduced by -0.88 kPa (95% CI -1.52 to -0.24 kPa) in the LRM group and by -0.36 kPa (95% CI -0.96 to 0.24 kPa) in the PSG group. These pilot data provide support to undertake a clinical trial investigating the clinical effectiveness of attended limited respiratory monitoring and PSG to establish NIV in patients with COPD-OSA overlap. TRIAL NUMBER: Results, NCT02444806. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: non invasive ventilation; sleep apnoea
Mesh:
Substances:
Year: 2018 PMID: 29602814 DOI: 10.1136/thoraxjnl-2017-211067
Source DB: PubMed Journal: Thorax ISSN: 0040-6376 Impact factor: 9.139